MedTrace Logo

Effect of Emdogain® on Soft Tissue Wound Healing

NCT06179277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2023-12-21

No results posted yet for this study

Summary

The goal of this randomized, controlled, single-center study is to compare the effects of Emdogain®, a regenerative biomaterial, on post-operative pain, wound healing and inflammation of treated sites after surgical crown lengthening. The main question it aims to answer is:

Does the use of Emdogain® in conjunction with crown lengthening surgery improve post-operative soft-tissue healing, decrease inflammation and reduce patient perception of pain compared to crown lengthening without addition of Emdogain®? The treatment group will receive Emdogain® during surgery, and the control group will undergo standard crown lengthening without Emdogain®.

Conditions

  • Periodontal Inflammation
  • Crown Lengthening

Interventions

DEVICE

PrefGel® + Emdogain®

Surgical crown lengthening procedure with root conditioning with 24% EDTA (PrefGel®) and application of 0.3 mL Emdogain® to root surface with 27-gauge needle

DEVICE

PrefGel®

Surgical crown lengthening procedure with root conditioning with 24% EDTA (PrefGel®)

Sponsors & Collaborators

  • Institut Straumann AG

    collaborator INDUSTRY

  • Amir Azarpazhooh

    lead OTHER

Principal Investigators

  • Howard Tenenbaum, Dr · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-08
Primary Completion
2020-11-09
Completion
2021-10-11

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06179277 on ClinicalTrials.gov